Mental Health Awareness Month: Fighting the growing mental health crisis and supporting innovation

America is currently facing a mental health crisis — one that is impacting families and individuals in every community, with the COVID-19 pandemic only exacerbating these trends. Mental Health...
Read More
Support for continued progress is critical for pediatric drug development

Researching and developing new medicines for children is a priority for the biopharmaceutical industry. Despite the scientific complexity and challenges inherent to developing treatments for our...
Read More
New resource underscores the importance of small molecule medicines

A small molecule medicine is what most people think of when they imagine a medicine. These medicines typically come in the form of a tablet or capsule and are usually taken by mouth. These medicines...
Read More
Policies need to address the growing threat of antimicrobial resistance

Today, the House Energy & Commerce Subcommittee on Oversight and Investigations will be holding a hearing on the growing public health threat of antimicrobial resistance (AMR). AMR occurs when...
Read More
World IP Day 2023: Celebrating women leaders in innovation

Today PhRMA joins with innovators around the globe to recognize World IP Day and celebrate biopharmaceutical innovators who dedicate their lives to bringing new treatments and cures to patients. It’s...
Read More
CMS guidance on IRA price setting process doubles down on bad policy

As part of the implementation of the Inflation Reduction Act (IRA), the Centers for Medicare & Medicaid Services (CMS) issued draft guidance on the process for setting the price of medicines. The...
Read More
A guide to MedPAC’s Part B vote today

Today, the Medicare Payment Advisory Commission (MedPAC), an independent congressional agency that advises Congress on issues related to the Medicare program, will vote on draft recommendations...
Read More
ICYMI: PhRMA President and CEO Stephen J. Ubl discusses patient affordability

PhRMA president and CEO Stephen J. Ubl spoke recently at The Hill’s event, “Pathways to Patient Affordability.” He spotlighted patients’ affordability challenges, the unintended consequences we’re...
Read More
New Report: More than 400 medicines in development for leading chronic conditions affecting older Americans

Chronic diseases like Alzheimer’s disease, diabetes and kidney disease disproportionately affect older adults. In the United States, nearly 95% of older adults have at least one chronic condition and...
Read More
Celebrating the success of the COVID-19 vaccines, and looking to the future

It’s been over three years since I saw my first COVID-19 patient in the emergency department. The image of that x-ray is burned into my memory: clusters of white spots spread out across both sides of...
Read More